Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02472717Phase 2Withdrawn
Phase 2, randomised, double-blind trial of liraglutide in psoriatic arthritis (PsA), sponsored by University Health Network. Planned start May 2015; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02472717.